IL1B and type 2 diabetes mellitus: Hodgson et al. have demonstrated in a mouse model of T2DM that 24 h after a subcutaneous injection of B. pseudomallei the expression of IFN-γ, TNF-α, IL-1β, IL-6, and IL-12 cytokines were decreased compared to non-diabetic controls (229).